has anyone gotten cancer from semaglutide GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for breast patients who are obese or have type 2 diabetes, according to new research. The study Is anyone afraid of the

J Clin Microbiol 2007;45:3077-3081

Bile starts out as a yellowish-greenish color and then turns brown during digestion

Incorporating New Chapters Omegas into your daily routine can help support heart health, including alongside GLP-1 therapies

The cornea of the eye harbors a rich array of immune cells and nerve fibers, making it susceptible to characteristic changes induced by systemic autoimmune and vasculitic diseases, resulting in corneal manifestations like immune cell infiltration, alterations in nerve fibers leading to changes in corneal mucosal tissues, decreased tear secretion, modifications in meibomian gland structure and function manifesting as symptoms and signs of dry eye syndrome, posing challenges in treatment [310]

95% CI, 0.947 to 9.646

While many trials (such as ELIXA for lixisenatide or TECOS for sitagliptin) established a noninferior relationship of antidiabetic agents compared with placebo, some showed superiority (such as LEADER for liraglutide and EMPA-REG for empagliflozin), and others raised separate concerns about additional CV outcomes, such as increased hospitalization for heart failure (e.g., SAVOR-TIMI 53 for saxagliptin)